Modification of oxytocin use through a coaching‐based intervention based on the WHO Safe Childbirth Checklist in Uttar Pradesh, India: a secondary analysis of a cluster randomised controlled trial. (25th August 2021)

• Record Type: Journal Article
• Authors: Marx Delaney, M; Kalita, T; Hawrusik, B; Neal, BJ; Miller, K; Ketchum, R; Molina, RL; Singh, S; Kumar, V; Semrau, KEA
• Is Part Of: BJOG. Volume 128:Number 12(2021)
• Page Start: 2013
• Page End: 2021
• Publication Date: 2021-08-25
• Subjects: India -- oxytocin -- quality of care -- WHO Safe Childbirth Checklist; Obstetrics -- Periodicals; Gynecology -- Periodicals; 618
• DOI: 10.1111/1471-0528.16856
• Languages: English
• ISSNs: 1470-0328

Abstract

Abstract : Objective: To understand the prevalence of intrapartum oxytocin use, assess associated perinatal and maternal outcomes, and evaluate the impact of a WHO Safe Childbirth Checklist intervention on oxytocin use at primary‐level facilities in Uttar Pradesh, India. Design: Secondary analysis of a cluster‐randomised controlled trial. Setting: Thirty Primary and Community public health facilities in Uttar Pradesh, India from 2014 to 2017. Population: Women admitted to a study facility for childbirth at baseline, 2, 6 or 12 months after intervention initiation. Methods: The BetterBirth intervention aimed to increase adherence to the WHO Safe Childbirth Checklist. We used Rao‐Scott Chi‐square tests to compare (1) timing of oxytocin use between study arms and (2) perinatal mortality and resuscitation of infants whose mothers received intrapartum oxytocin versus who did not. Main outcome measures: Intrapartum and postpartum oxytocin administration, perinatal mortality, use of neonatal bag and mask. Results: We observed 5484 deliveries. At baseline, intrapartum oxytocin was administered to 78.2% of women. Two months after intervention initiation, intrapartum oxytocin (I) was administered to 32.1% of women compared with 70.6% in the control (C) ( P < 0.01); this difference diminished after the end of the intervention (I = 48.2%, C = 74.7%, P = 0.03). Partograph use remained at <1% at all facilities. Resuscitation was performed on 7.5% of infants whose mother received intrapartum oxytocin versus 2.0% who did not ( P < 0.0001). Conclusions: In this setting, intrapartum oxytocin use was high despite limited maternal/fetal monitoring or caesarean capability, and was associated with increased neonatal resuscitation. The BetterBirth intervention was successful at decreasing intrapartum oxytocin use. Ongoing support is needed to sustain these practices. Tweetable abstract: Coaching + WHO Safe Childbirth Checklist reduces intrapartum oxytocin use and need for newborn resuscitation. Tweetable abstract: Coaching + WHO Safe Childbirth Checklist reduces intrapartum oxytocin use and need for newborn resuscitation.